nodes	percent_of_prediction	percent_of_DWPC	metapath
Naphazoline—Accidental exposure to product—Furosemide—dilated cardiomyopathy	0.215	0.323	CcSEcCtD
Naphazoline—Accidental ingestion—Furosemide—dilated cardiomyopathy	0.215	0.323	CcSEcCtD
Naphazoline—Drowsiness—Spironolactone—dilated cardiomyopathy	0.0208	0.0313	CcSEcCtD
Naphazoline—Discomfort—Spironolactone—dilated cardiomyopathy	0.0137	0.0206	CcSEcCtD
Naphazoline—Somnolence—Spironolactone—dilated cardiomyopathy	0.0118	0.0177	CcSEcCtD
Naphazoline—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.0115	0.0172	CcSEcCtD
Naphazoline—Drowsiness—Furosemide—dilated cardiomyopathy	0.0113	0.017	CcSEcCtD
Naphazoline—Sweating—Furosemide—dilated cardiomyopathy	0.0109	0.0163	CcSEcCtD
Naphazoline—Eye disorder—Furosemide—dilated cardiomyopathy	0.00951	0.0143	CcSEcCtD
Naphazoline—Erythema—Furosemide—dilated cardiomyopathy	0.00886	0.0133	CcSEcCtD
Naphazoline—Dizziness—Spironolactone—dilated cardiomyopathy	0.00878	0.0132	CcSEcCtD
Naphazoline—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.0086	0.0129	CcSEcCtD
Naphazoline—Vision blurred—Furosemide—dilated cardiomyopathy	0.00835	0.0125	CcSEcCtD
Naphazoline—Headache—Spironolactone—dilated cardiomyopathy	0.00832	0.0125	CcSEcCtD
Naphazoline—Sweating—Lisinopril—dilated cardiomyopathy	0.00815	0.0122	CcSEcCtD
Naphazoline—Nausea—Spironolactone—dilated cardiomyopathy	0.00789	0.0118	CcSEcCtD
Naphazoline—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00699	0.0105	CcSEcCtD
Naphazoline—Erythema—Lisinopril—dilated cardiomyopathy	0.00664	0.00998	CcSEcCtD
Naphazoline—Tension—Lisinopril—dilated cardiomyopathy	0.00652	0.00979	CcSEcCtD
Naphazoline—Nervousness—Lisinopril—dilated cardiomyopathy	0.00645	0.00969	CcSEcCtD
Naphazoline—Somnolence—Furosemide—dilated cardiomyopathy	0.00643	0.00965	CcSEcCtD
Naphazoline—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00626	0.0094	CcSEcCtD
Naphazoline—Discomfort—Lisinopril—dilated cardiomyopathy	0.00559	0.00839	CcSEcCtD
Naphazoline—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00524	0.00787	CcSEcCtD
Naphazoline—Asthenia—Furosemide—dilated cardiomyopathy	0.00519	0.00779	CcSEcCtD
Naphazoline—Somnolence—Lisinopril—dilated cardiomyopathy	0.00482	0.00724	CcSEcCtD
Naphazoline—Dizziness—Furosemide—dilated cardiomyopathy	0.00478	0.00718	CcSEcCtD
Naphazoline—Headache—Furosemide—dilated cardiomyopathy	0.00453	0.0068	CcSEcCtD
Naphazoline—Nausea—Furosemide—dilated cardiomyopathy	0.00429	0.00645	CcSEcCtD
Naphazoline—Asthenia—Lisinopril—dilated cardiomyopathy	0.00389	0.00584	CcSEcCtD
Naphazoline—Dizziness—Lisinopril—dilated cardiomyopathy	0.00359	0.00538	CcSEcCtD
Naphazoline—Headache—Lisinopril—dilated cardiomyopathy	0.0034	0.0051	CcSEcCtD
Naphazoline—Nausea—Lisinopril—dilated cardiomyopathy	0.00322	0.00484	CcSEcCtD
Naphazoline—Propranolol—ADRB1—dilated cardiomyopathy	0.00278	0.543	CrCbGaD
Naphazoline—Propranolol—ADRB2—dilated cardiomyopathy	0.00234	0.457	CrCbGaD
Naphazoline—ADRA2B—Hemostasis—ACTN2—dilated cardiomyopathy	0.00113	0.00344	CbGpPWpGaD
Naphazoline—ADRA1A—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.00111	0.00337	CbGpPWpGaD
Naphazoline—ADRA2C—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.0011	0.00335	CbGpPWpGaD
Naphazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.0011	0.00334	CbGpPWpGaD
Naphazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00109	0.00332	CbGpPWpGaD
Naphazoline—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00109	0.0033	CbGpPWpGaD
Naphazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00106	0.00322	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—ACTN2—dilated cardiomyopathy	0.00106	0.00322	CbGpPWpGaD
Naphazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00102	0.0031	CbGpPWpGaD
Naphazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00101	0.00306	CbGpPWpGaD
Naphazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00101	0.00306	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—TTN—dilated cardiomyopathy	0.00099	0.00301	CbGpPWpGaD
Naphazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000989	0.00301	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—VCL—dilated cardiomyopathy	0.000962	0.00293	CbGpPWpGaD
Naphazoline—ADRA2A—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000961	0.00292	CbGpPWpGaD
Naphazoline—ADRA2A—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000961	0.00292	CbGpPWpGaD
Naphazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00096	0.00292	CbGpPWpGaD
Naphazoline—ADRA1A—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.000955	0.0029	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000941	0.00286	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000941	0.00286	CbGpPWpGaD
Naphazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000936	0.00285	CbGpPWpGaD
Naphazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000907	0.00276	CbGpPWpGaD
Naphazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000904	0.00275	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—VCL—dilated cardiomyopathy	0.000899	0.00273	CbGpPWpGaD
Naphazoline—ADRA2A—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000893	0.00272	CbGpPWpGaD
Naphazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000892	0.00271	CbGpPWpGaD
Naphazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000892	0.00271	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000875	0.00266	CbGpPWpGaD
Naphazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000864	0.00263	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—ACTN2—dilated cardiomyopathy	0.000859	0.00261	CbGpPWpGaD
Naphazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000857	0.00261	CbGpPWpGaD
Naphazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.000854	0.0026	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000847	0.00258	CbGpPWpGaD
Naphazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000844	0.00257	CbGpPWpGaD
Naphazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000829	0.00252	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000822	0.0025	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000822	0.0025	CbGpPWpGaD
Naphazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000803	0.00244	CbGpPWpGaD
Naphazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000801	0.00244	CbGpPWpGaD
Naphazoline—ADRA2B—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.0008	0.00243	CbGpPWpGaD
Naphazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000774	0.00236	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000767	0.00233	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000767	0.00233	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000764	0.00233	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000764	0.00232	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000764	0.00232	CbGpPWpGaD
Naphazoline—ADRA2B—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000753	0.00229	CbGpPWpGaD
Naphazoline—ADRA2C—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.000747	0.00227	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00074	0.00225	CbGpPWpGaD
Naphazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000738	0.00224	CbGpPWpGaD
Naphazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000735	0.00223	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—VCL—dilated cardiomyopathy	0.00073	0.00222	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000723	0.0022	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000716	0.00218	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000716	0.00218	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000713	0.00217	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00071	0.00216	CbGpPWpGaD
Naphazoline—ADRA2C—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000704	0.00214	CbGpPWpGaD
Naphazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.0007	0.00213	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—ANKRD1—dilated cardiomyopathy	0.000694	0.00211	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00069	0.0021	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000688	0.00209	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000686	0.00209	CbGpPWpGaD
Naphazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000686	0.00209	CbGpPWpGaD
Naphazoline—ADRA2B—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000685	0.00208	CbGpPWpGaD
Naphazoline—ADRA1A—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000672	0.00204	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000666	0.00203	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—TAZ—dilated cardiomyopathy	0.000652	0.00198	CbGpPWpGaD
Naphazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000651	0.00198	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000645	0.00196	CbGpPWpGaD
Naphazoline—ADRA2C—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00064	0.00195	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000632	0.00192	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000626	0.0019	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000626	0.0019	CbGpPWpGaD
Naphazoline—ADRA2A—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.000607	0.00184	CbGpPWpGaD
Naphazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000601	0.00183	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.0006	0.00182	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—SDHA—dilated cardiomyopathy	0.00059	0.00179	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00059	0.00179	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000588	0.00179	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000582	0.00177	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000582	0.00177	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000582	0.00177	CbGpPWpGaD
Naphazoline—ADRA2A—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000572	0.00174	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000564	0.00171	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—ANKRD1—dilated cardiomyopathy	0.000564	0.00171	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000559	0.0017	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000557	0.0017	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000551	0.00168	CbGpPWpGaD
Naphazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000545	0.00166	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000541	0.00165	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—TAZ—dilated cardiomyopathy	0.00053	0.00161	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000524	0.00159	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000523	0.00159	CbGpPWpGaD
Naphazoline—ADRA2A—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00052	0.00158	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000509	0.00155	CbGpPWpGaD
Naphazoline—ADRA2B—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.0005	0.00152	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—ITGB1—dilated cardiomyopathy	0.000483	0.00147	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000482	0.00146	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—SDHA—dilated cardiomyopathy	0.000479	0.00146	CbGpPWpGaD
Naphazoline—ADRA2C—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000467	0.00142	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000457	0.00139	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—ITGB1—dilated cardiomyopathy	0.000451	0.00137	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000447	0.00136	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000445	0.00135	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000433	0.00132	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000433	0.00132	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000424	0.00129	CbGpPWpGaD
Naphazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000417	0.00127	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000415	0.00126	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000413	0.00126	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—CD36—dilated cardiomyopathy	0.000412	0.00125	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000405	0.00123	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000405	0.00123	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000403	0.00123	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000394	0.0012	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000394	0.0012	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00039	0.00119	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—RAC1—dilated cardiomyopathy	0.000388	0.00118	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000388	0.00118	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—CD36—dilated cardiomyopathy	0.000385	0.00117	CbGpPWpGaD
Naphazoline—ADRA2A—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000379	0.00115	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000376	0.00114	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000368	0.00112	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000368	0.00112	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—ITGB1—dilated cardiomyopathy	0.000367	0.00111	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000366	0.00111	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000364	0.00111	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—RAC1—dilated cardiomyopathy	0.000363	0.0011	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000354	0.00108	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000354	0.00108	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000354	0.00108	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000342	0.00104	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000339	0.00103	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000333	0.00101	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000331	0.00101	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000329	0.001	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000329	0.001	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000329	0.001	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000321	0.000977	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000321	0.000977	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000319	0.000969	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000316	0.000961	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000315	0.000958	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—CD36—dilated cardiomyopathy	0.000313	0.000951	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000311	0.000947	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000306	0.00093	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000303	0.00092	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000299	0.000909	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000299	0.000908	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000299	0.000908	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000296	0.0009	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000295	0.000898	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—RAC1—dilated cardiomyopathy	0.000295	0.000896	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000289	0.00088	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000287	0.000873	CbGpPWpGaD
Naphazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000286	0.00087	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000283	0.00086	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000278	0.000844	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000272	0.000828	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000269	0.000818	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000268	0.000816	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000262	0.000796	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000258	0.000785	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—RAF1—dilated cardiomyopathy	0.000258	0.000783	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000253	0.000769	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000247	0.000752	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000245	0.000746	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000245	0.000744	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—RAF1—dilated cardiomyopathy	0.000241	0.000732	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00024	0.00073	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000235	0.000713	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000234	0.000713	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000232	0.000707	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000232	0.000707	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00023	0.000698	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000229	0.000697	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000223	0.000678	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000219	0.000666	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000218	0.000662	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000217	0.00066	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000217	0.00066	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000216	0.000657	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000214	0.00065	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000213	0.000648	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000209	0.000637	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000208	0.000633	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000202	0.000614	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.0002	0.00061	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000199	0.000605	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000199	0.000604	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000196	0.000595	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	0.000195	0.000594	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000191	0.000582	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00019	0.000577	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00019	0.000577	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000186	0.000566	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000182	0.000554	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000179	0.000544	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000178	0.000541	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000176	0.000537	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000176	0.000536	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000176	0.000536	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000174	0.000529	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000171	0.00052	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00017	0.000516	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000169	0.000514	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000167	0.000508	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000164	0.000499	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000162	0.000491	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—GPX1—dilated cardiomyopathy	0.00016	0.000487	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000159	0.000483	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000158	0.000482	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—CD36—dilated cardiomyopathy	0.000156	0.000475	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000148	0.000449	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000146	0.000444	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000146	0.000443	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—AGT—dilated cardiomyopathy	0.000141	0.000427	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000138	0.000421	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000138	0.00042	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000136	0.000414	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000136	0.000413	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000132	0.0004	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	0.00013	0.000396	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000129	0.000391	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	0.000127	0.000386	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—AGT—dilated cardiomyopathy	0.000126	0.000383	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000123	0.000374	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000121	0.000367	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000119	0.000362	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—AGT—dilated cardiomyopathy	0.000118	0.000357	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	0.000114	0.000347	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000112	0.000341	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000111	0.000336	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000108	0.000327	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	0.000103	0.000312	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000101	0.000308	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	9.99e-05	0.000304	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	9.54e-05	0.00029	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	9.47e-05	0.000288	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—RAF1—dilated cardiomyopathy	8.73e-05	0.000266	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.28e-05	0.000252	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—RAF1—dilated cardiomyopathy	8.16e-05	0.000248	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.69e-05	0.000234	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	7.13e-05	0.000217	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	6.62e-05	0.000201	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—EGFR—dilated cardiomyopathy	5.99e-05	0.000182	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—EGFR—dilated cardiomyopathy	5.59e-05	0.00017	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	4.89e-05	0.000149	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	4.54e-05	0.000138	CbGpPWpGaD
